UnitedHealth Group Inc (UNH) stock analysis
Close on Nov 16, 2026Market cap $369.83BP/E 26.5Yield 2.12%
StockData Score
Prices as of Nov 16, 2026How the score works
Mixed11 of 30 checks passed
UnitedHealth passes 11 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 2/6
- Financial health
- 2/6
- Dividend
- 4/6
What stands out
Revenue growing 10%+ a year
Revenue grew 11.4% a year over the last three fiscal years.
Interest well covered
Operating income covers interest expense 5.6 times.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 36.8% of total debt.
Guidance raised
UnitedHealth raised its Full Year 2026 UnitedHealth Group Adjusted Operating Earnings outlook on Jul 16, 2026.
What to watch
Earnings shrank over 5 years
Net income shrank 4.8% a year on average over the last five fiscal years.
EPS growing under 10% a year
Diluted EPS grew -14.5% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -33.7% over the last twelve months, against a 5-year average of -4.8% a year.
P/E above its 5-year median
UnitedHealth's P/E of 26.5 is above its own 5-year median of 25.6.
Valuation0/6
P/E above its 5-year median
UnitedHealth's P/E of 26.5 is above its own 5-year median of 25.6.
P/E above the industry
UnitedHealth's P/E of 26.5 is above the Accident and Health Insurance and Medical median of 22.4.
P/S above the industry
UnitedHealth's price-to-sales of 0.82 is above the Accident and Health Insurance and Medical median of 0.82.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 11.4% a year over the last three fiscal years.
EPS growing under 10% a year
Diluted EPS grew -14.5% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -33.7% over the last twelve months, against a 5-year average of -4.8% a year.
Growing slower than the industry
Revenue grew 6.5% over the last twelve months; the Accident and Health Insurance and Medical median is 9.7%.
Guidance raised
UnitedHealth raised its Full Year 2026 UnitedHealth Group Adjusted Operating Earnings outlook on Jul 16, 2026.
Gross margin improving
Gross margin was 88.6% over the last twelve months, against 88.2% a year earlier.
Past performance2/6
Return on equity
Needs positive equity and five years of results.
Return on assets over 1%
Return on assets was 4.6%; for a bank or insurer, 1% or more is considered good.
Return on equity against the industry
Needs positive equity.
Earnings shrank over 5 years
Net income shrank 4.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 3.1% over the last twelve months, against a 5-year average of 4.9%.
Net margin above the industry
UnitedHealth's net margin of 3.1% is above the Accident and Health Insurance and Medical median of 2.5%.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 36.8% of total debt.
Interest well covered
Operating income covers interest expense 5.6 times.
Short-term assets don't cover short-term debts
Current assets are 0.78 times current liabilities.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend4/6
Pays a dividend
UnitedHealth paid dividends worth 2.2% of the share price over the last twelve months.
Yield below Treasuries
The 2.2% yield is below the 4.7% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.9% or more; UnitedHealth yields 2.2%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 57.3% of net income.
Covered by free cash flow
Dividends take 34.3% of free cash flow.
Fair value
How we estimate itWe don't publish a fair value for UnitedHealth. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 25.6
- Accident and Health Insurance and Medical median 22.4
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $2.30B
- Value traded per 1% price move
- $1.70B
Downside
Medium risk
- Typical loss in a bad month
- 19.4%
- Volatility (annualized)
- 34%
- Sharpe ratio, 1 year
- 0.56
- Beta to the S&P 500 (5Y)
- 0.61
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +11.8% | +11.4% | +11.7% | +11.0% | |
| Gross profit | +12.3% | +11.0% | +11.9% | +10.9% | |
| Operating income | -41.3% | -12.6% | -3.3% | +5.6% | |
| Net income | -16.3% | -15.7% | -4.8% | +7.6% | |
| EPS, diluted | -14.7% | -14.5% | -3.8% | +8.2% | |
| Free cash flow | -22.4% | -11.8% | -4.4% | +7.0% | |
| Dividend per share | +6.7% | +10.9% | +12.6% | +16.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | 6.0% | 8.3% | 4.0% | |
| Current ratio | 0.69 | 0.74 | 0.79 | |
| Net debt to EBITDA | 1.50× | 1.05× | 2.32× | |
| Interest coverage | 12.1× | 13.5× | 4.7× | |
| Inventory turnover | – | – | 14.3× | |
| Capex to revenue | 0.9% | 0.8% | 0.8% | |
| Diluted shares | 968M | 961M | 911M |
Where the cash went
Fiscal 2021 to 2025, five years combined
UnitedHealth generated $121.52B from operations and spent $83.79B on capital expenditure, dividends and share buybacks. 19% of that went back into the business.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$12.06B
- Cash generatingOperating cash flow above zero$19.70B
- Return on assets improvedROA up on the prior year5.3% → 4.0%
- Earnings backed by cashOperating cash flow above net income$19.70B vs $12.06B
- Less leverageLong-term debt to assets fell24.3% → 23.4%
- Better liquidityCurrent ratio rose0.83 → 0.79
- No dilutionShare count did not rise929M → 911M
- Gross margin improvedGross margin up on the prior year88.33% → 88.68%
- More efficientAsset turnover rose1.46 → 1.50
See a number that looks wrong?